Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K
Skeletal Muscle Anatomy00:55

Skeletal Muscle Anatomy

94.1K
Skeletal muscle is the most abundant type of muscle in the body. Tendons are the connective tissue that attaches skeletal muscle to bones. Skeletal muscles pull on tendons, which in turn pull on bones to carry out voluntary movements.
94.1K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Skin Cancer01:30

Skin Cancer

6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study.

Head & neck·2024
Same author

Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Biocompatibility of Water-Dispersible Pristine Graphene and Graphene Oxide Using a Close-to-Human Animal Model: A Pilot Study on Swine.

Advanced healthcare materials·2024
Same author

Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.

Neuro-oncology·2024
Same author

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study).

European journal of cancer (Oxford, England : 1990)·2024

Related Experiment Video

Updated: Mar 15, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K

Sarcomas of Soft Tissue and Bone.

Andrea Ferrari, Uta Dirksen, Stefan Bielack

    Progress in Tumor Research
    |September 6, 2016
    PubMed
    Summary

    Soft tissue and bone sarcomas are aggressive cancers in young adults. Improved treatment requires collaboration between pediatric and adult oncologists, ideally through international clinical trials.

    Area of Science:

    • Oncology
    • Malignant Neoplasms

    Background:

    • Soft tissue and bone sarcomas are heterogeneous mesenchymal malignancies.
    • Rhabdomyosarcoma, synovial sarcoma, Ewing sarcoma, and osteosarcoma are aggressive subtypes.
    • These sarcomas frequently affect adolescents and young adults.

    Purpose of the Study:

    • To highlight the clinical challenges in managing sarcomas in adolescents and young adults.
    • To emphasize the need for collaborative therapeutic approaches.
    • To advocate for the inclusion of these patients in international clinical trials.

    Main Methods:

    • Review of current management strategies for pediatric and adult sarcoma patients.
    • Analysis of treatment discrepancies between pediatric and adult oncology.
    • Discussion of the benefits of interdisciplinary cooperation and clinical trial participation.

    More Related Videos

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.4K
    Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
    09:25

    Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

    Published on: October 14, 2016

    19.7K

    Related Experiment Videos

    Last Updated: Mar 15, 2026

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    15.3K
    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.4K
    Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
    09:25

    Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

    Published on: October 14, 2016

    19.7K

    Main Results:

    • Disparate treatment protocols are often applied by pediatric and adult oncologists for similar sarcoma types.
    • Effective management necessitates a unified approach.
    • International clinical trials offer a platform for standardized and advanced care.

    Conclusions:

    • Cooperation between pediatric and adult oncologists is crucial for optimal sarcoma patient care.
    • Integrating patients into international clinical trials is essential for advancing treatment outcomes.
    • A multidisciplinary approach ensures comprehensive management of these aggressive malignancies.